Clinical analysis of non-invasive positive pressure ventilation and transnasal high-flow oxygen therapy for AECOPD complicated with respiratory failure type Ⅱ

doi:10.3877/cma.j.issn.1674-6902.2023.03.009

Abstract

Ruiping Xuan, Xiaoqin Liu, Ping Wang. Clinical analysis of non-invasive positive pressure ventilation and transnasal high-flow oxygen therapy for AECOPD complicated with respiratory failure type Ⅱ[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(03): 346-348.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfbjbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6902.2023.03.009

https://zhfbjbzz.cma-cmc.com.cn/EN/Y2023/V16/I03/346

Figures/Tables 2

References 26

1	Sarkar M, Sinha R, Roychowdhoury S, et al. Comparative study between noninvasive continuous positive airway pressure and hot humidified high-flow nasal cannulae as a mode of respiratory support in infants with acute bronchiolitis in pediatric intensive care unit of a tertiary care hospital[J]. Indian J Crit Care Med, 2018, 22(2): 85-90.
2	任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
3	Xia JH. Effect of noninvasive positive pressure ventilation on acute exacerbation of chronic obstructive pulmonary disease with severetypeⅡrespiratory failure[J]. Chinese J Med, 2019, 54(7): 772-774.
4	Gupta BK, Saha AK, Mukherjee S, et al. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial[J]. Eur J Pediatr, 2020, 179(8): 1287-1293.
5	Hu K, Zhao H, Lu YJ. Application of high-flow nasal cannula in patients with type Ⅱ respiratory failure of AECOPD[J]. J Clin Pul Med, 2018, 23(8): 1420-1422.
6	Huang LN, Li ZD, Xia JG, et al. Applicaion of high-flow nasal cannula oxygen therapy in the treatment of acute respiratory failure[J]. Chinese J Tuber & Respir Dis, 2019, 42(1): 41-44.
7	慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志，2017, 37(14): 1041-1057.
8	王庸晋，金明根，翁孝刚. 内科学[M]. 北京：人民军医出版社，2010: 41.
9	Erhabor GE, Adeniyi B, Arawomo AO, et al. Acute exacerbation of COPD: Clinical perspectives and literature review[J]. West Afr J Med, 2021, 38(11): 1129-1142.
10	Adibi A, Sin DD, Safari A, et al. The acute COPD exacerbation prediction tool (ACCEPT): a modelling study[J]. Lancet Respir Med, 2020, 8(10): 1013-1021.
11	Mosier JM, Hypes C, Joshi R, et al. Ventilator strategies and rescue therapies for management of acute respiratory failure in the emergency department[J]. Ann Emerg Med, 2015, 66(5): 529-541.
12	Combret Y, Prieur G, Roux PL, et al. Non-invasive ventilation improves respiratory distress in children with acute viral bronchiolitis: A systematic review[J]. Minerva Anestesiol, 2017, 83(6): 624-637.
13	Köhnlein T, Schwarz SB, Nagel S, et al. Home non-invasive positive pressure ventilation in chronic obstructive pulmonary disease: why, who, and how? [J]. Respiration, 2022, 101(8): 709-716.
14	Hu K, Zhao H, Lu YJ. Application of high-flow nasal cannula in patients with type Ⅱ respiratory failure of AECOPD[J]. J Clin Pul Med, 2018, 23(8): 1420-1422.
15	Guo FY, Ran L, Liu H X, et al. Efficacy and airway management of humidified high flow nasal cannula oxygen therapy in treatment of postoperative acute respiratory failure after extubation[J]. Inter J Respir, 2019, 39(6): 429-433.
16	刘易其，李冬琼，陈明菊，等. 经鼻高流量湿化氧疗与无创正压通气治疗慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭患者疗效的研究[J]. 泸州医学院学报，2020, 43(4): 349-353.
17	杨慧亮，李　颖，巴晓彤. 时间控制通气模式对COPD合并Ⅱ型呼吸衰竭患者血气分析和呼吸力学指标的影响[J]. 临床和实验医学杂志，2020, 19(18): 1937-1940.
18	刘晓曼，胡秀娟，国莉莉，等. 无创正压通气中SXX模式治疗对COPD合并Ⅱ型呼吸衰竭患者呼吸力学指标，肺功能及并发症的影响[J]. 解放军医药杂志，2021, 33(6): 59-62.
19	洪原城，宋媛媛，黄种杰，等. 无创通气联合雾化吸入早期治疗对重症哮喘患者临床症状及血气指标的影响[J]. 热带医学杂志，2016, 16(10): 1278-1280.
20	Akizuki M, Serizawa N, Ueno A, et al. Effect of balloon pulmonary angioplasty on respiratory function in patients with chronic thromboembolic pulmonary hypertension[J]. Chest, 2017, 151(3): 643-649.
21	Xu WY, Shi GC. Nasal high flow oxygen therapy for chronic obstructive pulmonary disease with hypercapnia[J]. Chinese J General Practitioners, 2019, 18(12): 1186-1189.
22	杨双嘉，邝　敏，邓嘉宁，等. 噻托溴铵联合无创正压通气对慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者症状评分、肺功能及血气分析指标的影响[J]. 广西医科大学学报，2020, 37(1): 61-67.
23	江美芳，刘　蔺，秦　克. 噻托溴铵联合无创呼吸机治疗COPD合并Ⅱ型呼吸衰竭疗效及对患者血气指标和炎症因子的影响[J]. 标记免疫分析与临床，2020, 27(1): 132-135, 141.
24	姬　峰，张　鹏，亓　梅，等. 经鼻高流量氧疗联合参芪扶正注射液对COPD合并Ⅱ型呼吸衰竭患者动脉血气、炎性因子及免疫功能的影响[J]. 现代生物医学进展，2021, 21(17): 3300-3304.
25	陈　颖，万久贺，王　红，等. 无创通气与经鼻高流量氧疗治疗COPD合并Ⅱ型呼吸衰竭的临床疗效[J]. 国际呼吸杂志，2020, 40(20): 1570-1575.
26	谈定玉，凌冰玉，孙家艳，等. 经鼻高流量氧疗与无创正压通气比较治疗慢性阻塞性肺疾病合并中度呼吸衰竭的观察性队列研究[J]. 中华急诊医学杂志，2018, 27(4): 361-366.

组　别	例数	PaO₂(mmHg)		SaO₂(%)		PaCO₂(mmHg)		OI(mmHg)
组　别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	56	46.02±5.03	90.02±9.06^a	68.90±4.11	98.04±1.78^a	64.02±6.74	36.45±4.77^a	261.09±8.65	378.95±16.22^a
对照组	50	45.87±4.98	69.97±8.77^a	68.87±4.32	84.52±5.09^a	63.55±6.45	48.72±5.88^a	261.11±8.33	299.45±15.64^a
t值		0.154	11.547	0.037	18.650	0.366	11.850	0.012	25.618
P值		0.878	0.000	0.971	0.000	0.715	0.000	0.990	0.000

组　别	例数	PaO₂(mmHg)		SaO₂(%)		PaCO₂(mmHg)		OI(mmHg)
组　别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	56	46.02±5.03	90.02±9.06^a	68.90±4.11	98.04±1.78^a	64.02±6.74	36.45±4.77^a	261.09±8.65	378.95±16.22^a
对照组	50	45.87±4.98	69.97±8.77^a	68.87±4.32	84.52±5.09^a	63.55±6.45	48.72±5.88^a	261.11±8.33	299.45±15.64^a
t值		0.154	11.547	0.037	18.650	0.366	11.850	0.012	25.618
P值		0.878	0.000	0.971	0.000	0.715	0.000	0.990	0.000

组　别	例数	IL-10(ng/L)		PCT(ng/ml)		CRP(mg/L)		TNF-α(ng/L)
组　别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	56	3.80±0.55	15.27±1.55^a	6.48±0.27	3.09±0.18^a	12.30±1.80	5.07±1.65^a	78.34±9.33	27.25±3.88^a
对照组	50	3.78±0.41	11.34±1.40^a	6.50±0.30	4.27±0.22^a	12.28±1.77	9.75±2.34^a	78.65±9.78	42.05±5.03^a
t值		0.210	13.637	0.361	30.347	0.058	11.997	0.167	17.059
P值		0.834	0.000	0.719	0.000	0.954	0.001	0.868	0.000

组　别	例数	IL-10(ng/L)		PCT(ng/ml)		CRP(mg/L)		TNF-α(ng/L)
组　别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
观察组	56	3.80±0.55	15.27±1.55^a	6.48±0.27	3.09±0.18^a	12.30±1.80	5.07±1.65^a	78.34±9.33	27.25±3.88^a
对照组	50	3.78±0.41	11.34±1.40^a	6.50±0.30	4.27±0.22^a	12.28±1.77	9.75±2.34^a	78.65±9.78	42.05±5.03^a
t值		0.210	13.637	0.361	30.347	0.058	11.997	0.167	17.059
P值		0.834	0.000	0.719	0.000	0.954	0.001	0.868	0.000

Please choose a citation manager

Content to export

Clinical analysis of non-invasive positive pressure ventilation and transnasal high-flow oxygen therapy for AECOPD complicated with respiratory failure type Ⅱ

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 26

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Clinical analysis of non-invasive positive pressure ventilation and transnasal high-flow oxygen therapy for AECOPD complicated with respiratory failure type Ⅱ

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 26

Related Articles 0

Recommended Articles

Metrics

Comments